Serotonin is a tiny chemical that helps the brain control mood, sleep, and digestion. Recent studies also show that it can affect a small heart piece called the mitral valve.
What the Mitral Valve Does
The mitral valve sits between the left upper chamber (atrium) and the left lower chamber (ventricle) of the heart. When the heart squeezes, the valve closes tightly so blood moves forward, not backward.
When the valve tissue becomes weak—called degenerative mitral regurgitation (DMR)—the flaps can get thick or stretched. The valve then leaks, letting blood flow back toward the lungs. This can cause tiredness, shortness of breath, and extra strain on the heart.
Why Serotonin Matters for the Valve
Besides its brain jobs, serotonin talks to many cells in the body. It binds to receptors on cell surfaces, sending signals that tell the cell what to do.
After sending a signal, a protein called the serotonin transporter (SERT) pulls serotonin back into the cell. This “re‑uptake” ends the signal. Some antidepressants—known as SSRIs—slow down SERT, leaving more serotonin outside the cell for a longer time.
Link Between SSRIs and Faster Valve Wear
Researchers looked at over 9,000 people who had mitral‑valve surgery. They also examined 100 tiny valve samples in the lab.
People who took SSRIs tended to need surgery at a younger age than those who did not. The study could only show a connection, not that SSRIs cause the valve to get worse.
To explore the idea, scientists used two mouse models:
- Mice without the SERT gene developed thicker mitral valves.
- Normal mice given high doses of SSRIs also showed thicker valves.
These experiments suggest that very low SERT activity can change valve shape.
Genetic Clues: The 5‑HTTLPR Variant
Inside the SERT gene is a region called 5‑HTTLPR. Some people have a “long‑long” version that makes the transporter work less well.
Patients with DMR who carried the long‑long version needed valve surgery more often than those with other versions. Lab cells from these patients produced extra collagen when exposed to serotonin, making the valve stiffer.
Could a Simple DNA Test Help?
Scientists propose a quick genetic test that looks for the long‑long variant. The test could use a drop of blood or a cheek swab. Knowing a patient’s SERT activity might let doctors watch the valve more closely or plan surgery earlier.
Today, guidelines still rely on symptoms, imaging, and how much blood leaks. More research is needed before DNA testing becomes routine.
Important Things to Remember
The findings do NOT mean that normal doses of SSRIs damage a healthy valve. In a healthy heart, low SERT activity is unlikely to cause problems on its own.
People with already weakened mitral valves may be more sensitive to serotonin and to drugs that lower SERT. This does NOT mean anyone should stop their antidepressant without talking to a doctor.
What New Research Shows
Since 2023, other studies have added pieces to the puzzle:
- 2024 mouse work linked low SERT to fibrosis (scar‑like tissue) in both heart valves and heart muscle, highlighting a receptor called HTR2B.
- 2025 research on aortic stenosis (a different valve problem) found higher blood serotonin in patients with the disease.
- Early 2026 experiments showed that blocking HTR2B in mice protected valve shape and blood flow.
- A 2026 review of many clinical studies reported that drugs affecting SERT were tied to a higher chance of valve disease (odds ratio ≈ 2.8), though causation was not proven.
All these clues point to serotonin signaling as a possible factor in valve remodeling, but human proof is still missing.
Take‑Home Message
For people with degenerative mitral regurgitation, regular check‑ups with a cardiologist remain the best plan. Understanding serotonin’s role may one day help doctors spot at‑risk patients or create new medicines that protect heart valves without messing up serotonin’s many other jobs.
Until then, keep talking to your heart doctor about symptoms and follow their advice about medication, imaging, and possible surgery.